NO871917L - Fremgangsmaate for fremstilling av nye styryl-pyrazoler og -isoksazoler og analoger derav. - Google Patents

Fremgangsmaate for fremstilling av nye styryl-pyrazoler og -isoksazoler og analoger derav.

Info

Publication number
NO871917L
NO871917L NO871917A NO871917A NO871917L NO 871917 L NO871917 L NO 871917L NO 871917 A NO871917 A NO 871917A NO 871917 A NO871917 A NO 871917A NO 871917 L NO871917 L NO 871917L
Authority
NO
Norway
Prior art keywords
analogs
isocozols
procedure
preparation
pyrazoles
Prior art date
Application number
NO871917A
Other languages
English (en)
Norwegian (no)
Other versions
NO871917D0 (no
Inventor
Thomas R Belliotti
David T Connor
Daniel L Flynn
Catherine R Kostlan
Donald E Nies
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO871917D0 publication Critical patent/NO871917D0/no
Publication of NO871917L publication Critical patent/NO871917L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/653—Five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
NO871917A 1986-05-09 1987-05-08 Fremgangsmaate for fremstilling av nye styryl-pyrazoler og -isoksazoler og analoger derav. NO871917L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86117986A 1986-05-09 1986-05-09
US91069286A 1986-09-22 1986-09-22
US3273087A 1987-04-06 1987-04-06

Publications (2)

Publication Number Publication Date
NO871917D0 NO871917D0 (no) 1987-05-08
NO871917L true NO871917L (no) 1987-11-10

Family

ID=27364200

Family Applications (1)

Application Number Title Priority Date Filing Date
NO871917A NO871917L (no) 1986-05-09 1987-05-08 Fremgangsmaate for fremstilling av nye styryl-pyrazoler og -isoksazoler og analoger derav.

Country Status (15)

Country Link
US (1) US5208251A (xx)
EP (1) EP0245825B1 (xx)
JP (1) JP2656035B2 (xx)
KR (1) KR870011113A (xx)
AT (1) ATE61582T1 (xx)
AU (1) AU613579B2 (xx)
DE (1) DE3768553D1 (xx)
DK (1) DK175824B1 (xx)
ES (1) ES2037681T3 (xx)
FI (1) FI872015A (xx)
GR (1) GR3001831T3 (xx)
IE (1) IE59813B1 (xx)
NO (1) NO871917L (xx)
NZ (1) NZ220248A (xx)
PT (1) PT84840B (xx)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL91418A (en) * 1988-09-01 1997-11-20 Rhone Poulenc Agrochimie (hetero) cyclic amide derivatives, process for their preparation and fungicidal compositions containing them
DE3923649A1 (de) * 1989-07-18 1991-01-31 Hoechst Ag Neue pyrazoline und ihre verwendung als safener
GB8920519D0 (en) * 1989-09-11 1989-10-25 Rhone Poulenc Ltd New compositions of matter
DE3939010A1 (de) * 1989-11-25 1991-05-29 Hoechst Ag Isoxazoline, verfahren zu ihrer herstellung und ihre verwendung als pflanzenschuetzende mittel
US5324840A (en) 1992-06-11 1994-06-28 Allergan, Inc. Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects
JPH06135948A (ja) * 1992-10-30 1994-05-17 Taiho Yakuhin Kogyo Kk スチレン誘導体又はその塩
JP2738486B2 (ja) * 1992-11-20 1998-04-08 ファイザー製薬株式会社 抗炎症剤としての新規なイソオキサゾリン類
US5973160A (en) * 1992-12-23 1999-10-26 Poss; Michael A. Methods for the preparation of novel sidechain-bearing taxanes
US5455265A (en) 1993-02-11 1995-10-03 Allergan, Inc. Method of treatment with compounds having selective agonist-like activity on RXR retinoid receptors
US6172115B1 (en) 1993-02-11 2001-01-09 Allergan Sales, Inc. Method for preventing onset of restenosis after angioplasty employing an RXR-specific retinoid
ES2139754T3 (es) * 1993-11-26 2000-02-16 Pfizer 3-fenil-2-isoxazolinas como agentes antiinflamatorios.
WO1995024192A1 (en) * 1994-03-09 1995-09-14 Pfizer Inc. Isoxazoline compounds as 5-lipoxygenase inhibitors
DE4408084A1 (de) * 1994-03-10 1995-09-14 Hoechst Ag 3,5-Disubstituierte und 3,4,5-trisubstituierte 2-Isoxazoline und Isoxazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US5510361A (en) * 1994-10-20 1996-04-23 The Procter & Gamble Company Di-tert-butylphenol compounds with heterocyclic moiety, useful as anti-inflammatory agents
CA2170661A1 (en) 1995-03-22 1996-09-23 John K. Thottathil Novel methods for the preparation of taxanes using oaxzolidine intermediates
US6011052A (en) * 1996-04-30 2000-01-04 Warner-Lambert Company Pyrazolone derivatives as MCP-1 antagonists
EP0966452B1 (de) * 1997-01-17 2003-05-02 Basf Aktiengesellschaft Verfahren zur herstellung von schwefelhaltigen 2-chlor-3-(4,5-dihydroisoxazol-3-yl)-benzoesäuren
AU2474399A (en) 1998-01-26 1999-08-09 Mitokor Mitochondria protecting agents for treating mitochondria associated diseases
ATE433106T1 (de) 1998-12-23 2009-06-15 Glaxo Group Ltd Bestimmungsmethode fur liganden der nuklearen rezeptoren
CN100462354C (zh) * 2001-01-18 2009-02-18 天济药业（深圳）有限公司 治疗免疫疾病的新的1,2-二苯基乙烯衍生物
DE10121252A1 (de) * 2001-04-30 2002-11-07 Christos C Zouboulis Behandlung der Akne
WO2003105751A2 (en) * 2002-06-17 2003-12-24 Ho-Jeong Kwon Novel curcumin derivatives
FR2842806B1 (fr) * 2002-07-26 2005-07-29 Mayoly Spindler Lab Nouveau procede de preparation de derives styryle pyrazoles, isoxazoles et isothiazoles
WO2004037793A1 (ja) * 2002-10-24 2004-05-06 Wakamoto Pharmaceutical Co., Ltd. シクロオキシゲナーゼ及び５−リポキシゲナーゼを阻害するピラゾール−４−アルカン酸誘導体
FR2846232B1 (fr) * 2002-10-29 2004-12-10 Oreal Composition capillaire contenant un compose styryl-pyrazole, son utilisation pour stimuler ou induire la pousse des cheveux et/ou freiner leur chute
EP1558203B1 (fr) * 2002-10-29 2007-05-09 L'oreal Composition capillaire contenant un compose styryl-pyrazole
JP5063351B2 (ja) * 2004-09-17 2012-10-31 エグゼリクシス， インコーポレイテッド ピラゾールキナーゼモジュレーターおよび使用方法
KR100604696B1 (ko) * 2004-12-16 2006-07-31 연세대학교 산학협력단 신규한 커큐민 유도체
EP1901618B1 (en) * 2005-07-05 2009-06-17 Symrise GmbH & Co. KG Hydroxyphenylalkadiones and their use for masking bitter taste and/or for intensifying sweet taste
US8329757B2 (en) * 2008-10-14 2012-12-11 Charlesson, Llc Curcumin analog compositions and related methods
MY198422A (en) 2009-04-29 2023-08-29 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
CA2832650C (en) 2011-04-11 2019-05-07 Pharma Eight Co. Ltd. Pyrazole derivative
KR102212146B1 (ko) * 2012-10-10 2021-02-03 그린 테크 가부시키가이샤 신규 피라졸 유도체
JP6052673B2 (ja) * 2013-04-25 2016-12-27 富士フイルム株式会社 ピラゾール誘導体またはその塩ならびにそれらを含有する医薬組成物
CN104304244B (zh) * 2014-09-11 2016-08-24 广西田园生化股份有限公司 一种用于农药制剂中的抗紫外线吸收剂
US11325901B2 (en) 2016-06-28 2022-05-10 University Of Kentucky Research Foundation Prostaglandin E synthase inhibitors and methods for utilizing the same

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3133080A (en) * 1964-05-12 Optical whitening agents of the
US2640056A (en) * 1949-06-03 1953-05-26 Ilford Ltd Pyrazoline sulphonic acids
GB669590A (en) * 1949-06-03 1952-04-02 Ilford Ltd Improvements in or relating to a process for improving the whiteness of colour materials
US2721143A (en) * 1950-11-18 1955-10-18 Knoll Ag 3-phenyl pyrazol compounds and preserved composition containing said compounds
DE1039743B (de) * 1957-03-27 1958-09-25 Bayer Ag Verfahren zur Stabilisierung von halogenhaltigen Polymerisaten und Mischpolymerisaten aus Vinylhalogeniden
US3239533A (en) * 1963-01-24 1966-03-08 Shionogi & Co (phenyl-isoxazolyl)-diazomethylketones
DE1287997B (xx) * 1964-04-05 1969-01-23
US3551440A (en) * 1966-07-25 1970-12-29 Bristol Myers Co 3 phenyl - 5(alkyl)isothiazole - 4 - carboxylic acids and intermediates thereof
US3631169A (en) * 1966-09-22 1971-12-28 Dainippon Pharmaceutical Co 3-(5-nitro-2-furyl)isoxazoline derivatives
US3772284A (en) * 1966-12-20 1973-11-13 American Cyanamid Co Azirine compounds
US3479365A (en) * 1967-05-19 1969-11-18 Bristol Banyu Res Inst Ltd New isothiazole synthesis
GB1164510A (en) * 1967-06-15 1969-09-17 Ici Ltd Novel Isoxazole Derivatives, the preparation thereof, and Compositions containing the same
US3464999A (en) * 1967-07-27 1969-09-02 R & L Molecular Research Ltd Thiadiazolylisothiazoles
GB1180268A (en) * 1967-09-26 1970-02-04 Ici Ltd Pharmaceutically Active Phenyl-Heterocyclic-Alkanol Derivatives
US3835126A (en) * 1968-04-19 1974-09-10 Hoechst Ag Styryl-pyrazoline compounds
DE1900349A1 (de) * 1969-01-04 1970-08-06 Basf Ag Neue Pyrazolinderivate
FR2073284B1 (xx) * 1969-12-23 1973-07-13 Ferlux
US3711495A (en) * 1970-01-07 1973-01-16 Merck & Co Inc Isoxazalin-3-yl-substituted-5-nitroimidazoles
US3687971A (en) * 1970-06-22 1972-08-29 Merck & Co Inc 4-(pyrrolyl)-salicylic acid derivatives
GB1373212A (en) * 1970-12-07 1974-11-06 Wyeth John & Brother Ltd Pyrazole compounds
US4045169A (en) * 1971-09-09 1977-08-30 Hoechst Aktiengesellschaft 3-[3',4'-Dichloro-6'-alkyl-phenyl]-Δ 2-pyrazoline derivatives and their use as optical brighteners
US3948937A (en) * 1972-02-29 1976-04-06 E. I. Du Pont De Nemours And Company Pyrazole plant growth regulants
US3849436A (en) * 1972-10-04 1974-11-19 Du Pont Cyclization of 2-(3-aryl-5-pyrazolyl)benzoic acids,esters and amides to 2-arylpyrazolo(5,1-a)isoindol-8-ones
US3895027A (en) * 1974-04-12 1975-07-15 Lilly Co Eli Process for preparing pyrazole-3-carboxylic acids
US3910949A (en) * 1974-12-09 1975-10-07 American Cyanamid Co Manufacture of 1,2-dimethyl-3,5-diphenylpyrazolium methylsulfate in a single reaction zone
DE2526469A1 (de) * 1975-06-13 1976-12-30 Bayer Ag 1-substituierte pyrazolderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2536003C2 (de) * 1975-08-08 1985-11-14 Schering AG, 1000 Berlin und 4709 Bergkamen Pyrazol-Derivate, ihre Herstellung und diese enthaltende pharmazeutische Derivate
US4032644A (en) * 1975-12-29 1977-06-28 Sandoz, Inc. Isoxazolyl benzoic acids
US4153707A (en) * 1976-08-12 1979-05-08 The Upjohn Company Fungicidal isoxazolyl phenols and method of use
US4140515A (en) * 1977-05-12 1979-02-20 Monsanto Company Aryl-3-isoxazole benzoates as plant growth regulants and herbicides
US4129568A (en) * 1977-05-12 1978-12-12 Monsanto Company 2-[3-Aryl-2-isoxazolin-5-yl]benzoates
US4139366A (en) * 1977-05-12 1979-02-13 Monsanto Company 2-[5-aryl-2-isoxazolin-3-yl]benzoates and use as herbicides
SU717046A1 (ru) * 1978-03-01 1980-02-25 Предприятие П/Я Р-6496 Способ получени 3-арил-5-фенил-1(4-формилфенил)-2-пиразолинов
DE2818999A1 (de) * 1978-04-29 1979-11-15 Basf Ag Aminoderivate von 3-alkyl-5-(2- hydroxystyryl)-isoxazolen
DD138770A1 (de) * 1978-09-20 1979-11-21 Juergen Liebscher Verfahren zur herstellung von 5-styryl-pyrazolen und ihren vinylogen
US4229204A (en) * 1978-12-04 1980-10-21 Monsanto Company Trifluoromethylphenyl isoxazolyl benzoates
SU792872A1 (ru) * 1979-01-15 1981-09-07 Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латсср Способ получени 2-(изоксазолил-5)-бензойных кислот
JPS6043064B2 (ja) * 1979-11-28 1985-09-26 ウェルファイド株式会社 新規イソオキサゾ−ル誘導体
DE3006809A1 (de) * 1980-02-23 1981-09-24 Basf Ag, 6700 Ludwigshafen 2-((3-amino-2-hydroxy-propoxy)-styryl)-isoxazole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
JPS5740468A (en) * 1980-08-25 1982-03-06 Kuraray Co Ltd Vinyl substituted pyrazole derivative and its preparation
US4346094A (en) * 1980-09-22 1982-08-24 Eli Lilly And Company 3-Aryl-5-isothiazolecarboxylic acids and related compounds used to lower uric acid levels
ZA818703B (en) * 1980-12-16 1983-07-27 Wellcome Found Heterocyclic compounds
DE3148291A1 (de) * 1981-12-05 1983-06-09 Basf Ag, 6700 Ludwigshafen Harnstoffderivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
JPS58177977A (ja) * 1982-04-09 1983-10-18 Grelan Pharmaceut Co Ltd ４−フエニルピラゾ−ル類
US4495195A (en) * 1982-11-01 1985-01-22 Eli Lilly And Company Xanthine oxidase inhibiting 3(5)-phenyl-substituted-5(3)-pyrazole-carboxylic acid derivatives, compositions, and methods of use
US4451476A (en) * 1982-12-13 1984-05-29 Sterling Drug Inc. Isoxazoles as antiviral agents
CA1299176C (en) * 1985-07-02 1992-04-21 Guy Dominic Diana Process for preparing isoxazole and furan derivatives
DE3418395A1 (de) * 1984-05-17 1985-11-21 Bayer Ag, 5090 Leverkusen Biologisch aktive mittel enthaltend substituierte isoxazolidine sowie neue isoxazolidine und ihre herstellung
US4560695A (en) * 1984-06-18 1985-12-24 Eli Lilly And Company Isoxazolyl and isothiazolyl aromatase inhibitors
US4609666A (en) * 1984-06-18 1986-09-02 Eli Lilly And Company Aromatase inhibiting derivatives of α,α-bis(4-halophenyl)methyltetrazoles and triazoles
AU611437B2 (en) * 1987-05-29 1991-06-13 Ortho Pharmaceutical Corporation Pharmacologically active 2- and 3-substituted (1',5'-diaryl-3-pyrazolyl)-n-hydroxypropanamides and method for synthesizing the same
JPS6440266A (en) * 1987-08-04 1989-02-10 Toshiba Machine Co Ltd Working pressure control device for polishing machine

Also Published As

Publication number Publication date
PT84840B (pt) 1990-02-08
ES2037681T3 (es) 1993-07-01
DK226987D0 (da) 1987-05-04
FI872015A (fi) 1987-11-10
DK175824B1 (da) 2005-03-14
DK226987A (da) 1987-11-10
EP0245825B1 (en) 1991-03-13
GR3001831T3 (en) 1992-11-23
US5208251A (en) 1993-05-04
IE871041L (en) 1987-11-09
KR870011113A (ko) 1987-12-21
AU613579B2 (en) 1991-08-08
ATE61582T1 (de) 1991-03-15
PT84840A (en) 1987-06-01
JP2656035B2 (ja) 1997-09-24
FI872015A0 (fi) 1987-05-06
DE3768553D1 (de) 1991-04-18
AU7197387A (en) 1987-11-12
NO871917D0 (no) 1987-05-08
EP0245825A1 (en) 1987-11-19
JPS6322079A (ja) 1988-01-29
NZ220248A (en) 1989-05-29
IE59813B1 (en) 1994-04-06

Similar Documents

Publication Publication Date Title
NO871917L (no) Fremgangsmaate for fremstilling av nye styryl-pyrazoler og -isoksazoler og analoger derav.
DK154287A (da) Substituerede oxadiazol-derivater, fremgangsmaade til fremstilling deraf og mellemprodukter til brug ved fremgangsmaaden samt laegemiddel indeholdende oxadiazolerne
DE3773879D1 (de) Temperaturregelung, bei der der steuerparameter der grad der fehlanpassung der impedanz ist.
NO165959C (no) Analogifremgangsmaate ved fremstilling av 3,5-disubstituerte pyrokatekolderivater.
NO871640L (no) Fremgangsmaate for fremstilling av n-(2[-aminofenyl)-benzamidderivater.
NO149389C (no) Fremgangsmaate til fremstilling av 4,1`,6`-triklor-4,1`,6`-trideoksy-galaktosukrose
DK164700C (da) 3,4-disubstituerede 1,2,5-thiadiazol-1-oxider eller -1,1-dioxider
NO152091C (no) Analogifremgangsmaate ved fremstilling av antiinflammatorisk virksomme 5-substituerte 2,3-difenylthiofener
IT8248149A0 (it) Procedimento per l'ossidazione dicomposti aromatici
NO149957C (no) Fremgangsmaate for fremstilling av 4-(6`-metoksy-2`-naftyl)butan-2-on.
NO902548L (no) Fremgangsmaate for fremstilling av fenamat-1,3,4-tiadiazoler og 1,3,4 oksadiazoler.
NO155557C (no) Termostatisk foeler og framgangsmaate for framstilling av slik.
NO800920L (no) Fremgangsmaate til fremstilling av nye 1,8-dihydroksy-10-acyl-9-antroner for behandling av psoriasis
NO152771C (no) Fremgangsmaate for varmebehandling av nymelket melk samt varmebehandlingsanordning for samme.
NO830839L (no) Ny fremgangsmaate for fremstilling av 3,4-difenyl-5-metylpyrazolderivater.
NO895212L (no) Konstanttrykkregulering av hoevelblad.
NO822801L (no) Fremgangsmaate ved fremstilling av terapeutisk aktivt 2,5 disubstituerte furaner
FI906162A0 (fi) Foerfarande foer framstaellning av 3-(n-metyl-n-alkyl)-amino-2-metoximetylenpropan-1-olderivat.
NO873353D0 (no) Fremgangsmaate for fremstilling av antibakterielle 7-okso-4-tia-1-azabicyklo(3.2.0)hept-2-en-derivater.
FI820923L (fi) Foerfarande foer framstaellning av 2-amino-5-(o-sulfamidofenyl)-1,3,4-tiadiazolderivat
FI800106A (fi) Foerfarande foer separering av d,1 2-(6-metoxi-2-naftyl)propionsyra
NO894037D0 (no) Fremgangsmaate for fremstilling av nye 2-metoksykarbonyl-substituerte n,n'-di(trimetoksybenzoyl) piperaziner.
TR23391A (tr) Yeni tiofen bilesikleri ve bunlarin hazirlanmasi
RO80297A (ro) Procedeu pentru prepararea d,1-6-oxo-4,5,6,7-tetrahidro-1h-(sau 2h)-indazolulul
NO882862D0 (no) Fremgangsmaate for fremstilling av 2-(1-pentyl-3-guanidino)-4-(2 metyl-4-imidazolyl) tiazol og analoger derav.